Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-21-069717
Filing Date
2021-03-04
Accepted
2021-03-04 17:13:51
Documents
4
Effectiveness Date
2021-03-04

Document Format Files

Seq Description Document Type Size
1 S-8 POS d132682ds8pos.htm S-8 POS 54281
2 EX-5.1 d132682dex51.htm EX-5.1 5016
3 EX-23.1 d132682dex231.htm EX-23.1 1743
4 EX-99.3 d132682dex993.htm EX-99.3 80510
  Complete submission text file 0001193125-21-069717.txt   142563
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Filer) CIK: 0001627281 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-227717 | Film No.: 21715231
SIC: 2836 Biological Products, (No Diagnostic Substances)